Leukodystrophy Center

Comprehensive Care, Novel Therapies, and Pioneering Research

Our multidisciplinary team of specialists has unsurpassed, world-class experience in the diagnosis, monitoring and care of pediatric and adult patients with inherited leukodystrophies. The team at University of Minnesota Masonic Children’s Hospital was the first in the world to treat a patient with leukodystrophy (Globoid Cell Leukodystrophy, or GLD) with bone marrow transplantation. Since that time, we have treated more than 200 leukodystrophy patients with hematopoietic cell transplant (HCT), commonly known as blood and marrow transplant (BMT) and other therapies. Our team continues to have unsurpassed, world class experience treating patients with lysosomal and peroxisomal disorders affecting the nervous system. Our comprehensive leukodystrophy center includes a team of specialists from BMT, genetics, neurology, endocrinology, neuropsychology, neuroradiology, pharmacology, and physical and occupational therapy. This multidisciplinary team approach ensures that the care we provide best meets the unique needs of each patient and family.

We're here to help: Dr. Paul Orchard explains what to do after an ALD diagnosis from newborn screening

Resources for ALD (or adrenoleukodystrophy) newborn screening families

Katie Wiens discusses what having a child identified through newborn screening for ALD means for your entire family

Genetics counseling and ALD Newborn Screening: Resources for families